ZYBT

Index	-	P/E	284.38	EPS (ttm)	0.03	Insider Own	90.66%	Shs Outstand	47.17M	Perf Week	2.82%
Market Cap	448.78M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.43M	Perf Month	24.61%
Enterprise Value	467.27M	PEG	-	EPS next Q	-	Inst Own	0.89%	Short Float	4.49%	Perf Quarter	17.06%
Income	1.57M	P/S	17.33	EPS this Y	-	Inst Trans	0.41%	Short Ratio	1.12	Perf Half Y	101.92%
Sales	25.89M	P/B	11.48	EPS next Y	-	ROA	2.27%	Short Interest	0.20M	Perf YTD	94.86%
Book/sh	0.82	P/C	163.19	EPS next 5Y	-	ROE	4.06%	52W High	14.30 -33.78%	Perf Year	-
Cash/sh	0.06	P/FCF	117.18	EPS past 3/5Y	-36.18% -	ROIC	3.97%	52W Low	3.50 170.57%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	83.44	Sales past 3/5Y	-7.94% -	Gross Margin	48.96%	Volatility	15.09% 24.84%	Perf 5Y	-
Dividend TTM	-	EV/Sales	18.05	EPS Y/Y TTM	-64.87%	Oper. Margin	8.80%	ATR (14)	1.59	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.80	Sales Y/Y TTM	-13.57%	Profit Margin	6.06%	RSI (14)	53.34	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.31	EPS Q/Q	-79.39%	SMA20	3.94%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.30	Sales Q/Q	-2.78%	SMA50	28.60%	Rel Volume	0.64	Prev Close	9.55
Employees	277	LT Debt/Eq	0.02	Earnings	-	SMA200	42.75%	Avg Volume	176.85K	Price	9.47
IPO	Jan 07, 2025	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	112,614	Change	-0.84%

Jul-03-25 08:30AM	Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results (PR Newswire)
May-23-25 04:05PM	Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F (GlobeNewswire) -12.33%
Jan-14-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option (GlobeNewswire)
Jan-08-25 12:00PM	Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering (GlobeNewswire) -7.41%
Jan-06-25 05:50PM	Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Zhengye Biotechnology Holding Ltd

Upgrade your FINVIZ experience